DR 4004

Drug Profile

DR 4004

Latest Information Update: 10 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Meiji Seika Kaisha
  • Class Antidepressants; Anxiolytics; Sleep disorder therapies; Small molecules
  • Mechanism of Action Serotonin 7 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Sleep disorders

Most Recent Events

  • 10 Nov 2006 Discontinued - Preclinical for Sleep disorders in Japan (unspecified route)
  • 07 Jun 2001 No-Development-Reported for Sleep disorders in Japan (Unknown route)
  • 08 Dec 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top